Scancell Holdings Plc (LON:SCLP) has agreed another collaborative development for its Moditope anti-cancer platform. Dutch group ISA Pharmaceutical will incorporate its Amplivant technology into Modi-1, the first cancer treatment candidate being developed on the platform.
Mosman Oil And Gas Limited (LON:MSMN) has raised £500,000 of working capital through the issue of new shares in a placing. The junior oil firm is issuing a total of 45.45mln new shares at a price of 1.1p. According to Mosman, the funds will be put towards its evaluation of new acquisition opportunities and general purposes.
InnovaDerma PLC (LON:IDP) saw its top-line grow strongly in the first half of the current financial year and the beauty and personal care products developer expects further strong growth in the second half.
Regenerative medtech Collagen Solutions PLC (LON:COS) is to go it alone in China after ending its joint venture with distributor Cre8ive. Through the JV, Collagen had agreed import licences for its tissue material, established a pipeline of potential customers and signed two agreements, but having full control from now on would mean more flexibility.
UK healthcare firm Concepta PLC (LON:CPT) has signed a marketing agreement with Chinese Wei Yi Bei Lian Information Technology Co. Ltd (BB Link) which provides free WiFi in 1,500 maternity hospitals across China. When patients connect to BB Link's free WiFi service, Concepta’s landing page will be displayed with an overview of its myLotus fertility product.
NetScientific PLC (LON:NSCI), the transatlantic healthcare IP commercialisation group, said today that its portfolio company, ProAxsis, had conducted its first sale of NEATstik®, the company’s point-of-care test for measuring neutrophil elastase. The NEATstik® test, registered with a CE mark in the second half of 2017, was sold to a research laboratory conducting a respiratory clinical trial for a pharmaceutical company.
Pembridge Resources PLC (LON:PERE) is set to become a cash flow generating copper producer with the acquisition of Yukon-based Minto Explorations. Currently an acquisition vehicle or SPAC, Pembridge will pay US$37.5mln in cash to vendor Capstone Mining plus shares equivalent to a 9.9% stake in the enlarged company. Pembridge will then raise a further US$50mln to refinance the company and re-start exploration.
Stratex International plc (LON:STI) has teamed up with TET Madencilik to advance the Hasançelebi and Doğala gold projects in Turkey. The deal with TET, a private Turkish company, sees Stratex receive US$50,000 in cash and commits the new partner to spending US$1.5mln on exploration and drilling within a two-year period.
Tlou Energy Limited (LON:TLOU) has updated investors on its coal bed methane projects in Botswana following a debriefing meeting with the authorities. The meeting provided the company with more information following the government’s cancellation of a tendering process for CBM based power projects and confirmed that original bidders like Tlou would be asked to re-tender.
Mporium Group PLC (LON: MPM), the technology firm delivering event-driven marketing, said it has been notified that on 14 February 2018 its executive chairman, Barry Moat purchased 275,000 ordinary shares in the company at a price of 7p each. The group said it was also notified that its chief executive officer, Nelius De Groot also purchased 275,000 ordinary shares at a price of 7p each. Following these purchases, Moat's total shareholding in the company is 10,412,196 ordinary shares, representing approximately 1.77% of the voting share, while De Groot's total shareholding is 9,277,633 ordinary shares, representing approximately 1.58%.
ImmuPharma PLC (LON:IMM), specialist drug discovery and development company, announced that its chairman Tim McCarthy will be presenting at an investor evening hosted by Turner Pope Investments, which acted as agent in the firm’s recent £10mln fundraise. The group said the event will be held on Monday 26 February 2018 in London, EC2 and will commence at 6pm.
RM Secured Direct Lending PLC (LON:RMDL) announced that, as at 14 February 2018, it has deployed £25.05mmln of the proceeds of its C Share fundraising from October 2017, representing approximately 85.2% of the net proceeds of the share issue. The investment trust specialising in secured debt investments also declared an interim dividend of 2.0p per ordinary share in respect of the period from 1 October 2017 to 31 December 2017:
APQ Global Limited (LON:APQ), the AIM-listed emerging markets growth company announces that as at the close of business on 31 January 2018, the unaudited book value per ordinary share was 135.58 US cents.